Displaying drugs 226 - 250 of 6985 in total
Chloroquine
Chloroquine is an aminoquinolone derivative first developed in the 1940s for the treatment of malaria. It was the drug of choice to treat malaria until the development of newer antimalarials such as pyrimethamine, artemisinin, and mefloquine. Chloroquine and its derivative hydroxychloroquine have since been repurposed for the treatment of a...
Approved
Investigational
Vet approved
Matched Iupac: … 7-chloro-N-[5-(diethylamino)pentan-2-yl]quinolin-4-amine …
Matched Description: … FDA emergency use authorization for [hydroxychloroquine] and chloroquine in the treatment of COVID-19 …
Matched Salts cas: … 50-63-5 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Matched Products: … OROQUİNE 250 MG/5 ML IV İNFÜZYONLUK ÇÖZELTİ , 10 ADET …
Matched Description: … FDA emergency use authorization for [hydroxychloroquine] and chloroquine in the treatment of COVID-19 …
Matched Salts cas: … 50-63-5 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Matched Products: … OROQUİNE 250 MG/5 ML IV İNFÜZYONLUK ÇÖZELTİ , 10 ADET …
Natamycin
Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]
Approved
Matched Products: … NATACYN 5% STERILE OPHTHALMIC SUSPENSION ... NATACYN ® 5% SUSPENSION OFTALMICA ESTERIL ... NATACYN (NATAMYCIN 5%) OPHTHALMIC SUSPENSION …
Sibutramine
Sibutramine (trade name Meridia in the USA, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent for the treatment of obesity. It is a centrally acting stimulant chemically related to amphetamines thus it is classified as a Schedule IV controlled substance in the...
Approved
Illicit
Investigational
Withdrawn
Matched Products: … OBESTOPPOR 5 MG CAPSULAS …
Treosulfan
Treosulfan is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Approved
Investigational
Matched Products: … ALLOPRE 5 G İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 5 ADET ... ALLOPRE 5 G İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 1 ADET …
Methimazole
Methimazole is a thionamide antithyroid agent that inhibits the synthesis of thyroid hormones.[A184559,A184733,A184694] It was first introduced as an antithyroid agent in 1949 and is now commonly used in the management of hyperthyroidism, particularly in those for whom more aggressive options such as surgery or radioactive iodine therapy are inappropriate.[L8336,L8339]...
Approved
Matched Products: … VELTHROM 5 ... THYROZOL 5 ... THYROZOL TABLET 5 mg …
Azithromycin
Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration . It was initially approved by the FDA in 1991 .
It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for...
Approved
Matched Iupac: … 6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-2-ethyl-3,4,10-trihydroxy-13-{[(2R,4R,5S,6S)-5- …
Matched Description: … March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 …
Matched Salts cas: … 554432-19-8 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Matched Products: … ./ 5 มล.) ... AKRIBACT 200 MG/5 ML ... AZTROBAC 200 MG / 5 ML …
Matched Description: … March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 …
Matched Salts cas: … 554432-19-8 …
Matched Categories: … Experimental Unapproved Treatments for COVID-19 …
Matched Products: … ./ 5 มล.) ... AKRIBACT 200 MG/5 ML ... AZTROBAC 200 MG / 5 ML …
Terbutaline
Terbutaline was first synthesized in 1966 and described in the literature in the late 1960s and early 1970s. It is a selective beta-2 adrenergic agonist used as a bronchodilator in asthmatic patients.[A230333,L32093,L32098]
Terbutaline was granted FDA approval on 25 March 1974.
Approved
Matched Iupac: … 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol …
Matched Salts cas: … 23031-32-5 …
Matched Mixtures name: … BİCANA 1.5 MG/5 ML+66.5 MG/5 ML ŞURUP, 100 ML ... BRELAX 1,5 MG+66,5 MG/5 ML ŞURUP, 100 ML ... BECONYL 1,5 MG + 66,5 MG / 5 ML ŞURUP, 100 ML …
Matched Products: … Bricanyl Tab 5 mg ... BUTYLIN SYRUP 1.5 mg/5 ml ... ASMALIN SYRUP 1.5 mg/5 ml …
Matched Salts cas: … 23031-32-5 …
Matched Mixtures name: … BİCANA 1.5 MG/5 ML+66.5 MG/5 ML ŞURUP, 100 ML ... BRELAX 1,5 MG+66,5 MG/5 ML ŞURUP, 100 ML ... BECONYL 1,5 MG + 66,5 MG / 5 ML ŞURUP, 100 ML …
Matched Products: … Bricanyl Tab 5 mg ... BUTYLIN SYRUP 1.5 mg/5 ml ... ASMALIN SYRUP 1.5 mg/5 ml …
Treprostinil
Treprostinil is a stable tricyclic analogue of prostacyclin that promotes the vasodilation of pulmonary and systemic arterial vascular beds and the inhibition of platelet aggregation.[L41855,L41860,L41865] It reduces symptoms in patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease.[L41855,L41860] The first agent approved for the treatment...
Approved
Investigational
Matched Iupac: … -{[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H,2H,3H,3aH,4H,9H,9aH-cyclopenta[b]naphthalen-5- …
Matched Description: … However, the use of epoprostenol is limited due to its short half-life (3-5 min) and instability at room …
Matched Products: … REMODULIN 5 mg/ml Infusionslösung ... Treposa 5 mg/ml Infusionslösung ... Trisuva 5 mg/ml Infusionslösung …
Matched Description: … However, the use of epoprostenol is limited due to its short half-life (3-5 min) and instability at room …
Matched Products: … REMODULIN 5 mg/ml Infusionslösung ... Treposa 5 mg/ml Infusionslösung ... Trisuva 5 mg/ml Infusionslösung …
Solriamfetol
Solriamfetol marketed under the brand name Sunosi by Jazz Pharmaceuticals in the United States is a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated in treating daytime sleepiness associated with narcolepsy or obstructive sleep apnea[FDA Label]. Solriamfetol was given FDA approval in 2019[FDA Label].
Approved
Flurbiprofen
Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis....
Approved
Investigational
Matched Mixtures name: … MAJEZIK DUO %5 + %0.25 TOPIKAL JEL, 50 G ... MERDEX DUO %5 + %0.25 TOPIKAL JEL, 30 G ... MERDEX DUO %5 + %0.25 TOPIKAL JEL, 50 G …
Matched Products: … MAJEZIK %5 TOPIKAL JEL, 30 G ... MAJEZIK %5 TOPIKAL JEL, 50 G ... MAJEZIK % 5 TOPIKAL SPREY, ÇÖZELTİ, 50 ML …
Matched Products: … MAJEZIK %5 TOPIKAL JEL, 30 G ... MAJEZIK %5 TOPIKAL JEL, 50 G ... MAJEZIK % 5 TOPIKAL SPREY, ÇÖZELTİ, 50 ML …
Torasemide
Torasemide is a high-ceiling loop diuretic. Structurally, it is a pyridine-sulfonylurea used as an antihypertensive agent. Torasemide was first approved for clinical use by the FDA in 1993.
Approved
Matched Products: … TORASEMID 1A PHARMA 5 MG ... TORVENTA 5 MG TABLET, 20 ADET ... TORVENTA 5 MG TABLET, 30 ADET …
Etelcalcetide
Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
Approved
Investigational
Matched Products: … PARSABIV SOLUTION FOR INJECTION 5 mg/mL ... PARSABİV 5 MG/1 ML I.V. ENJEKSİYONLUK ÇÖZELTİ, 1 ADET ... PARSABİV 5 MG/1 ML I.V. ENJEKSİYONLUK ÇÖZELTİ, 6 ADET …
Cedazuridine
Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated.[A215082, A215092, A215097] Hypomethylating agents such as decitabine and azacitidine are used to treat MDS through inducing DNA hypomethylation and apoptosis of cancerous...
Approved
Investigational
Matched Iupac: … (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one …
Zaleplon
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States.
Approved
Illicit
Investigational
Matched Products: … SONATA ® 5 MG. CAPSULAS …
Antithymocyte immunoglobulin (rabbit)
Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of...
Approved
Matched Products: … Thymoglobuline 5 mg/ml - Pulver zur Herstellung einer Infusionslösung ... THYMOGLOBULİNE 5 MG-ML IV İNFÜZYON İÇİN LİYOFİLİZE TOZ İÇEREN FLAKON ... GRAFALON 5 ML IV INFUZYONLUK COZELTI KONSANTRESI ICEREN FLAKON, 1 ADET …
Morphine
Morphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805. It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse. Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength...
Approved
Investigational
Matched Products: … Vendal 5 mg/ml - orale Lösung ... MORFİN HİDROKLORÜR OSEL 0,02 G/1 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET …
Medroxyprogesterone acetate
Medroxyprogesterone acetate (MPA) is a progesterone derivative that is more resistant to metabolism for improved pharmacokinetic properties. MPA can be use to treat secondary amenorrhea, endometrial hyperplasia, abnormal uterine bleeding, osteoporosis, vasomotor symptoms in menopause, vulvar and vaginal atrophy, prevent pregnancy, manage pain in endometriosis, prevent pregnancy, and is also...
Approved
Investigational
Matched Mixtures name: … DIVICONT TABLETAS 1 MG/5 MG …
Matched Products: … Medroxy-5 ... โปรวีร่า (5 มก.) ... PROVERA TABLET 5 mg …
Matched Products: … Medroxy-5 ... โปรวีร่า (5 มก.) ... PROVERA TABLET 5 mg …
Betaxolol
A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Approved
Investigational
Matched Salts cas: … 63659-19-8 …
Matched Products: … BETOPTİC S %0,25 OFTALMİK SÜSPANSİYON, 5 ML ... BETOPTIC % 0.5 STERİL GÖZ DAMLASI, ÇÖZELTİ, 5 ML ... BETOPTIC-S % 0.25 STERİL GÖZ DAMLASI, SÜSPANSİYON, 5 ML …
Matched Products: … BETOPTİC S %0,25 OFTALMİK SÜSPANSİYON, 5 ML ... BETOPTIC % 0.5 STERİL GÖZ DAMLASI, ÇÖZELTİ, 5 ML ... BETOPTIC-S % 0.25 STERİL GÖZ DAMLASI, SÜSPANSİYON, 5 ML …
Glutamic acid
A peptide that is a homopolymer of glutamic acid.
Approved
Nutraceutical
Matched Mixtures name: … Aminosyn II 5% Inj ... AMINOPLASMAL-5% E INFUSION ... Numeta G 19 % E Emulsion zur Infusion …
Meperidine
A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.
Approved
Matched Salts cas: … 50-13-5 …
Matched Products: … ALDOLAN 50MG/1ML AMPUL, 5 ADET ... ALDOLAN 100 MG/2 ML AMPUL, 5 ADET ... ALDINE 100 MG/2 ML ENJEKSİYONLUK ÇÖZELTİ, 5 AMPUL …
Matched Products: … ALDOLAN 50MG/1ML AMPUL, 5 ADET ... ALDOLAN 100 MG/2 ML AMPUL, 5 ADET ... ALDINE 100 MG/2 ML ENJEKSİYONLUK ÇÖZELTİ, 5 AMPUL …
Lurasidone
Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
Approved
Investigational
Matched Categories: … Serotonin 5-HT1 Receptor Antagonists ... Serotonin 5-HT2 Receptor Antagonists ... Serotonin 5-HT1A Receptor Antagonists ... Serotonin 5-HT2A Receptor Antagonists …
Calcium glubionate anhydrous
Calcium glubionate (or glubionate calcium) is a mineral supplement to prevent or treat low blood calcium levels in people who do not get enough calcium from their diets.
Approved
Matched Products: … CALCIUM SANDOZ %10 AMPUL, 5 ADET ... CALCIUM SANDOZ 10 ML 1,375 GR AMPUL, 5 ADET …
Vilazodone
Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors[Label,A177622]. Vilazodone may also be associated with less sexual dysfunction and weight gain . Vilazodone was given FDA approval on January 21, 2011[L6046,A177622].
Approved
Matched Iupac: … 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide …
Matched Description: … (5-HT) transporter and 5-HT(1A) receptors[Label,A177622]. ... Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine …
Matched Categories: … Serotonin 5-HT1 Receptor Agonists …
Matched Description: … (5-HT) transporter and 5-HT(1A) receptors[Label,A177622]. ... Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine …
Matched Categories: … Serotonin 5-HT1 Receptor Agonists …
Pentoxifylline
Pentoxifylline (PTX) is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties.[A226415, L30300] Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated for its possible...
Approved
Investigational
Matched Iupac: … 3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione …
Matched Description: … [A226410, A226415, A226455] More recently, PTX has been suggested as a possible treatment for COVID-19 …
Matched Mixtures name: … Betamethasone Dipropionate 0.05% / Minoxidil 5% / Niacinamide 2% / Pentoxifylline 0.5% …
Matched Categories: … Phosphodiesterase 5 Inhibitors …
Matched Products: … ONPENT 100 MG/5 ML İ.V. İNFÜZYONLUK ÇÖZELTİ , 5 ADET ... HEMOPENE 100 MG 5 ML 10 AMPUL ... VASOPLAN 100 MG/5 ML IM/IV AMPUL …
Matched Description: … [A226410, A226415, A226455] More recently, PTX has been suggested as a possible treatment for COVID-19 …
Matched Mixtures name: … Betamethasone Dipropionate 0.05% / Minoxidil 5% / Niacinamide 2% / Pentoxifylline 0.5% …
Matched Categories: … Phosphodiesterase 5 Inhibitors …
Matched Products: … ONPENT 100 MG/5 ML İ.V. İNFÜZYONLUK ÇÖZELTİ , 5 ADET ... HEMOPENE 100 MG 5 ML 10 AMPUL ... VASOPLAN 100 MG/5 ML IM/IV AMPUL …
Vericiguat
Vericiguat is a direct stimulator of soluble guanylate cyclase (sGC) used in the management of systolic heart failure to reduce mortality and hospitalizations. A key component of the NO-sGC-cGMP signaling pathway that helps to regulate the cardiovascular system, sGC enzymes are intracellular enzymes found in vascular smooth muscle cells (amongst...
Approved
Investigational
Matched Iupac: … -5-yl)carbamate ... methyl N-(4,6-diamino-2-{5-fluoro-1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin …
Matched Products: … VERQUVO 5 MG FİLM KAPLI TABLET , 14 ADET ... VERQUVO 5 MG FİLM KAPLI TABLET , 28 ADET ... VERQUVO 5 MG FİLM KAPLI TABLET , 98 ADET …
Matched Products: … VERQUVO 5 MG FİLM KAPLI TABLET , 14 ADET ... VERQUVO 5 MG FİLM KAPLI TABLET , 28 ADET ... VERQUVO 5 MG FİLM KAPLI TABLET , 98 ADET …
Displaying drugs 226 - 250 of 6985 in total